FAIM Fragments Disassemble Neurodegenerative Protein Aggregates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases associated with protein misfolding and aggregation, such as Alzheimer's and Parkinson's, lack effective molecules to reverse disease progression and improve patient outcomes, with few mammalian homologs of Hsp104-like proteins identified.
Innovation Solution
Development of Fas Apoptosis Inhibitory Molecule (FAIM) fragments or mimetics with specific amino acid sequences that can bind and disassemble protein aggregates, administered therapeutically to treat neurodegenerative diseases by targeting misfolded proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Hsp104 is used to dissolve stress-induced protein aggregates, then protein aggregates are effectively disassembled, but Hsp104 has no metazoan homolog and cannot be applied to mammalian systems
Solution Approach 1:
The patent creates a functional copy of Hsp104's protein aggregate disassembly activity using FAIM fragments and mimetics. Instead of using the original Hsp104 protein from yeast, the invention synthesizes peptide fragments (such as FAIM1 fragments) that replicate the essential disaggregation function, making it applicable to mammalian systems where Hsp104 does not naturally exist.
2Reliability
If FAIM fragments or mimetics are administered to treat neurodegenerative diseases, then protein aggregates are disaggregated and disease progression may be reversed, but the specific amino acid sequence requirements and therapeutic dosing parameters must be precisely optimized
Solution Approach 1:
The patent systematically varies parameters including amino acid sequence identity (at least 70% identity to reference sequences), peptide length, and molecular weight to optimize therapeutic efficacy. Different FAIM fragments and mimetics are designed with specific sequence variations to achieve the desired balance between aggregate disassembly activity and therapeutic performance while minimizing off-target effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The FAIM fragments or mimetics effectively disaggregate protein complexes, providing a novel approach to treat neurodegenerative diseases by solubilizing established aggregates and protecting against protein aggregation, potentially reversing disease progression.
Implementation Method 1
molecules capable of binding and disassembling such protein assemblies, aggregates, and/or deposits may reverse disease progression
Implementation Method 2
The FAIM fragments or mimetics effectively disaggregate protein complexes, providing a novel approach to treat neurodegenerative diseases by solubilizing established aggregates
Data Source
AI summary
The present technology is directed to fragments of Fas Apoptosis Inhibitory Molecule (FAIM) or mimetics thereof, compositions containing FAIM or fragments and/or mimetics thereof, and methods of treatment and systems comprising FAIM or fragments and/or mimetics thereof. The methods of treatment include treating neurodegenerative neurodegenerative or other proteinopathy such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotropic lateral sclerosis, multiple tauopathies, spongiform encephalopathies, familial amyloidotic polyneuropathy, chronic traumatic encephalopathy, or a combination of two or more thereof.